Atrophic maxillary alveolar bone Atrophic maxillary alveolar bone
Conditions
Interventions
Use of allograft chips for maxillary sinus augmentation
Allografts, maxillary sinus augmentation
Sponsors
Ohba Seigo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who have a preference to receive a dental implant treatment for missing tooth in the maxillary posterior region. 2. Patients whose alveolar bone volume are insufficient for ideal implant placement, and are required the sinus floor augmentation for the dental implant placement. 3. Patients who can personally provide written consent at their own free will after being receiving a thorough explanation of the study and fully understanding their participation in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with problem in judgement. 2. Patients with drug hypersensitivity such as allergy. 3. Women who are or may be pregnant or lactating women. 4. Patients who are participating in another clinical study. 5. Patients are immunocompromised with severe diabetes or severe liver or renal dysfunction. 6. Patients with severe peptic ulcer or cardiovascular or respiratory diseases and disorders, 7. Smokers 8. Patients receiving therapies with anti-resorption drugs such as bisphosphonate which affect bone metabolism . 9. Partients who are judged to be inappropriate to participate the study by the principal or cooperative doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| augmentation volume | — |
Secondary
| Measure | Time frame |
|---|---|
| histological findings of allograft maxillary sinus membrane thickness safety | — |
Contacts
Public ContactSeigo Ohba
Nagasaki University Hospital
Outcome results
None listed